Amherst Massachusetts 01002
Amherst has long been a vibrant college town in the happy valley—complete with excellent educational opportunities for aspiring students and easy access to nature.
TMS was cleared in the United States by the FDA back in 2008 to help patients with treatment-resistant depression. In 2013 deep TMS was cleared by the FDA to help with this. Deep TMS was FDA approved in 2018 for OCD. It has also been CE approved in Europe for the treatment of bipolar disorder, PTSD, chronic pain, and adult ADHD.
Including studies and TMS treatment worldwide, TMS has helped with the following:
Insurance accepted for treating Depression, specifically TMS therapy, has more than doubled in the last few years, a sign that insurance companies must see cost savings in a treatment method for major depressive disorder (MDD) that works more efficiently than the traditional regimen alone. Patients who continually suffer from the debilitating effects of medication-resistant depression may acquire other health conditions as a result, such as a substance abuse disorder or unhealthy weight gain, to name a few. The fact that more and more insurance companies are providing coverage for TMS indicates a cost benefit to the insurer, thus the broadening of benefits.
The following are some of the insurance plans currently working with Achieve TMS East: Aetna, BCBS, BMC, Cigna, Commonwealth Care Alliance, Fallon Health, GIC, Harvard Pilgrim, Husky, Masshealth PCC Plan, Medicare, Neighborhood Health Plan, One Care, Tricare, Tufts Health Plan, and United Health Care. If you don’t see your plan listed, please call and ask us about yours today.